MedTrace Logo

Prediction and Detection of Occult Atrial Fibrillation in Patients After Acute Cryptogenic Stroke and TIA

NCT02725944 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 251

Last updated 2018-09-10

No results posted yet for this study

Summary

PROACTIA is a prospective, event-driven observational study. It aims to propose a composite scoring system in order to evaluate the risk of paroxysmal atrial fibrillation (PAF) in patients after acute cryptogenic stroke and transient ischemic attack (TIA).

Conditions

Interventions

DEVICE

Implantation of ICRM

All patients will be implanted with ICRM in order to detect an occult PAF.

Sponsors & Collaborators

  • University Hospital, Akershus

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-15
Primary Completion
2018-06-18
Completion
2018-06-18

Countries

  • Norway

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02725944 on ClinicalTrials.gov